PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1335

7 September announcement stating that first canine in USA had commenced mpl trial along with the information that they were waiting of blood data from another 8 dogs.
Well today is 24 November with only 5 trading days left in this month.
So first dog in USA should have well and truly finished their days, so where is the data for this dog or did HOT also move office or was it slow in sending blood results.
Announced 3 October first MND patient dozed with mpl, so this patient well and truly completed 28 days trial, should have finished at end of October.

Two weeks since AGM and a week since webinar what is going on, it appears nothing.
It's time that Management started taking responsibility for these delays, its time they started to show respect for shareholders by keeping them informed of where the company is progressing as so far their performance has been well below par.

Management having the ability to do deals well so far they haven't shown any, Roger has dangling the canine carrot for over two years and so far nothing.

At current sp of .077 and a mc of less than $25m, why would any major pharma pay millions for anything associated with PAA, especially considering the fact that Management can not even sell the science good news to the market to get the sp above 8 cents.
MND trial has commenced, first patient completed 28 days
Human cancer, great results back in 2015
Canine cancer great news since 2015
Epichem trial with Shell with OHD technology

I don't see another company listed on ASX with so much going for it at such a low MC, so one needs to look at why.
Delays, expected
Slow recruitment, expected
Lack of shareholder engagement, could be
Lack of ability of management, could be
Shareholders expectations to high, could be
Lack of interest of big pharmas, more than likely
Lack of funds, could be
Science data not what big pharmas want or insufficient, could be
Lack of understanding of the potential by market, could be
After 9 years of having mpl, reformulation etc etc and human cancer still hasn't progress to phrase 2 trial, could be